Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
---|
11/26/2003 | CN1128628C Chinese medicine for treating alopecia areata |
11/26/2003 | CN1128623C Instant effervescent particles for Ca-supplementing health-care products and its preparing process |
11/25/2003 | US6653354 Administering to the mammal xenon to modulate the activity of NMDA (N-methyl-D-aspartate) receptor, and a GABAergic agent, (sedative or anesthetics) thus preventing synaptic plasticity or relieving neuropathic pain |
11/25/2003 | US6652840 Aluminum chloride, ferric sulfate, regenerated oxidized cellulose, aluminum ammonium sulfate, absorbable gelatin and solvent; easy to use; reducing heart rate stimulation, staining, acid irritations and adhesive interference |
11/25/2003 | US6652479 Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments |
11/25/2003 | CA2180506C Inhalation of nitrogen monoxide for the prevention and the treatment of inflammatory reactions |
11/20/2003 | WO2003095436A1 Benzoisoselenazole derivatives with anti-inflammation, antivirus and anti-thrombosis activity and their use |
11/20/2003 | WO2003095085A1 Colloidal dispersion of calcium phosphate nanoparticles and at least one protein, and corresponding redispersible and calcined nanoparticles, preparation method and uses |
11/20/2003 | WO2003094984A1 Bone outgrowth agent and therapeutic agent for osteoporosis |
11/20/2003 | WO2003094952A1 Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
11/20/2003 | WO2003094934A1 Medicine for prevention of and treatment for amyloidosis |
11/20/2003 | WO2003094933A2 Use of lanthanum for the treatment of hypercalcemia and bone metastasis |
11/20/2003 | WO2003094932A1 Carbon monoxide as a biomarker and therapeutic agent |
11/20/2003 | WO2003094922A1 Use of cisplatin in combination with folic acid for increasing cisplatin efficacy |
11/20/2003 | WO2003094902A2 Surface treatment of sars-infected lungs |
11/20/2003 | WO2003094881A1 Composition and the use thereof as a pharmaceutical or cosmetic formulation for external use |
11/20/2003 | WO2003007970A3 Use of magnesium for preventing in-stent thrombosis and complications after arterial angioplasty with stent placement |
11/20/2003 | WO2002100420A3 Pharmaceutical zeolite-based compositions containing zinc and erythromycin, to be used in the treatment of acne |
11/20/2003 | US20030216777 Method of enhancing healing of interfacial gap between bone and tendon or ligament |
11/20/2003 | US20030216377 Vitronectin receptor antagonist |
11/20/2003 | US20030216359 Administering vitamin D or a derivative and a cytotoxic agent or a glucocorticoid and, optionally, a bisphosphonate |
11/20/2003 | US20030216348 Aminosugar, glycosaminoglycan, and S-Adenosylmethionine composition for the treatment and repair of connective tissue |
11/20/2003 | US20030215528 Prophylaxis and prevention of cancer, tumors, hyperplasia, hypertrophy or dysplasia comprising administering nitrates such as nitroglycerin; angiogenesis inhibitors |
11/20/2003 | US20030215527 Novel substituted benzimidazole dosage forms and method of using same |
11/20/2003 | US20030215526 Stable formulations of angiotensin converting enzyme (ACE) inhibitors |
11/20/2003 | US20030215525 Heat treated suspensions comprising group III compounds, preservatives, antideposit agents and optionally adjuvants, used for prophylaxis of gastrointestinal disorders |
11/20/2003 | US20030215524 Stable pharmaceutical composition useful for treating gastrointestinal disorders |
11/20/2003 | US20030215522 Personal care compositions comprising a zinc containing material in an aqueous surfactant composition |
11/20/2003 | US20030215521 Plastic containers, plates, films or fibers, having group IB compounds such as silver zirconium phosphate as microbiocides |
11/20/2003 | US20030215520 Generation of ozone and oxygen from air, then flowing the gas mixture into water using a venturi; water treatment |
11/20/2003 | US20030215491 Method and composition for rapid delivery of bioactive compounds to the systemic circulation via the nasal membrane |
11/20/2003 | US20030215404 Composition and method for inhibiting polar capsule discharge and protecting a subject from nematocyst sting |
11/20/2003 | US20030215401 Potassium or strontium salt as a nerve desensitizing agent; tubule blocking agent, that may be a hydrolyzed long-chain olefin-maleic anhydride copolymer |
11/20/2003 | US20030215388 Can be administered in conjunction with radiation or chemotherapeutic agents. |
11/20/2003 | US20030213937 Precipitated aragonite and a process for producing it |
11/20/2003 | CA2511749A1 Surface treatment of sars-infected lung |
11/20/2003 | CA2484770A1 Carbon monoxide as a biomarker and therapeutic agent |
11/19/2003 | EP1362885A1 Antimicrobially treated material and methods of preventing coloring thereof |
11/19/2003 | EP1362598A1 Active oxygen generator containing photosensitizer for ultrasonic therapy |
11/19/2003 | EP1362061A2 Antibodies that bind both bcma and taci |
11/19/2003 | EP1361884A2 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
11/19/2003 | EP0914111B1 Prevention and treatment of cachexia and anorexia |
11/19/2003 | CN1457261A Method and compositions for prevention or treatment of cancer |
11/19/2003 | CN1456338A Medicine for treating diabets mellitus |
11/19/2003 | CN1456333A Capsules against thrombus and preparation thereof |
11/19/2003 | CN1456313A Tiegudan for ischemic necrosis of fernoral head |
11/19/2003 | CN1456217A Medicine for curing choleithiasis and preparing method thereof |
11/19/2003 | CN1456172A Healthy vitamin nutrient solution |
11/19/2003 | CN1456171A Compound electrolyte intra-ocular flushing liquor |
11/19/2003 | CN1127976C Exterior-applied Chinese-medicinal pill for treatnig diarrhea |
11/19/2003 | CN1127974C Chinese medicinal preparation for fracture |
11/19/2003 | CN1127970C Ointment for treating burn and its preparing process |
11/19/2003 | CN1127967C Capsules for hypertension and their preparation |
11/19/2003 | CN1127964C Chinese medicine for treating dermatopathy (leukoderma and psoriasis) |
11/19/2003 | CN1127962C Capsule for curing hydrocephalus and its producing method |
11/19/2003 | CN1127961C Exterior-applied medicine for treatnig dermatopathy and its preparing process |
11/19/2003 | CN1127960C Eyesight improving medicine liquid |
11/18/2003 | US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
11/18/2003 | US6649645 Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia |
11/18/2003 | US6649195 Eyesight enhanced maintenance composition |
11/18/2003 | US6649193 Biomedically acceptable, cage-like compounds, including cobalamin (vitamin B12), potassium silicate and colloidal silicates and aluminosilicates such as zeolites encage atomic hydrogen in a |
11/18/2003 | US6649179 A plasminogen activator inhibitor comprising zinc oxide which adsorbs a plasminogen activator and inhibits its activity, thus improving rough skin |
11/18/2003 | US6649147 Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip |
11/18/2003 | US6649145 Wound healing, treating infections |
11/13/2003 | WO2003093478A1 Immunoconjugates for the treatment of tumours |
11/13/2003 | WO2003093322A2 Carrageenan based antimicrobial compositions |
11/13/2003 | WO2003092763A1 Carbon nanotubules for storage of nitric oxide |
11/13/2003 | WO2003092730A1 Hydroxycitric acid salt composition and method of making |
11/13/2003 | WO2003092707A1 Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass |
11/13/2003 | WO2003092703A1 Methods and compositions for inhibition or irritation by disaccharide and metal ions |
11/13/2003 | WO2003092691A1 Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia |
11/13/2003 | WO2003092674A1 Prenatal multivitamin/multimineral supplement |
11/13/2003 | WO2003092647A2 Transport system in biological systems |
11/13/2003 | WO2003092613A2 Catechin multimers as therapeutic drug delivery agents |
11/13/2003 | WO2003092589A2 Salt solution for colon cleansing |
11/13/2003 | WO2003092468A2 Biomatrix structural containment and fixation systems and methods of use thereof |
11/13/2003 | WO2003061588A3 Method of increasing fertility and athletic performance in horses |
11/13/2003 | WO2003020262A3 Use of polyunsaturated fatty acids for intra-arterial injection for selectively occluding blood supplies to neoplasias |
11/13/2003 | WO2003000065A3 Tooth whitening chewing gum |
11/13/2003 | WO2002062354A8 Allergen neutralization compositions containing aluminum ions |
11/13/2003 | WO2002018278A8 Method and apparatus for preparing aqueous dispersion of ultra-fine active carbon particles |
11/13/2003 | WO2002013826A9 Anti-cancer composition composed of anti-cancer and anti-malarial drugs |
11/13/2003 | US20030212073 Imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof |
11/13/2003 | US20030211607 Antisense modulation of survivin expression |
11/13/2003 | US20030211210 Using 1,3-dibromo-5,5-dimethylhydantoin in aqueous solution |
11/13/2003 | US20030211173 Lubrication composition |
11/13/2003 | US20030211172 Composition and method for substantially reducing the deleterious effects of alcohol on the body |
11/13/2003 | US20030211171 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
11/13/2003 | US20030211170 Wound healing agents |
11/13/2003 | US20030211133 Mixture of methylcobalamin and vitamin b |
11/13/2003 | US20030211132 Method for reducing radioactivity in the human body |
11/13/2003 | CA2484312A1 Catechin multimers as therapeutic drug delivery agents |
11/13/2003 | CA2484303A1 Salt solution for colon cleansing |
11/13/2003 | CA2483785A1 Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia |
11/13/2003 | CA2483778A1 Biomatrix structural containment and fixation systems and methods of use thereof |
11/13/2003 | CA2462879A1 Immunoconjugates for the treatment of tumours |
11/12/2003 | EP1360957A1 Vitamin/mineral complex |
11/12/2003 | EP1360508A2 Prediction of wound healing by urinary nitrate assay |
11/12/2003 | EP1359923A1 Use of selenite or preparations containing selenite for treating wounds |
11/12/2003 | EP0999819B1 Physiological combination of active substances to enhance the skin's defenses against noxious agents |